| Fund ID | 805-9127733326 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 6% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Broadoak Fund V | Private Equity | $113.7M |
| Broadoak Fund IV | Private Equity | $75.8M |
| Broadoak Capital 2019c, LLC | Private Equity | $64.6M |
Broadoak Biotools Venture Fund, LLC reports $6.2 million in gross assets, among the top 82% of private funds by size.
The stated minimum investment is $250,000.
Broadoak Biotools Venture Fund, LLC is managed by Broadoak Asset Management, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.